Literature DB >> 7612648

Isolation and characterisation of a vitronectin-binding surface protein from Staphylococcus aureus.

O D Liang1, J I Flock, T Wadström.   

Abstract

In a previous study we demonstrated that cells of Staphylococcus aureus strain V8 bind 125I-labelled vitronectin in a receptor-ligand type of interaction, and a protein having a molecular mass of 60 kDa was identified as a putative high-affinity staphylococcal vitronectin-binding protein (Liang, O.D. et al. (1993) Biochim. Biophys. Acta 1225, 57-63). In the present communication we report on the isolation and preliminary characterisation of the 60 kDa vitronectin-binding protein. The bacterial cell surface proteins were released by stirring bacteria with 1 M LiCl at 37 degrees C for 2 h and separated on an FPLC Mono-Q column with a gradient of 0-0.5 M NaCl in 20 mM Tris buffer at pH 9.0. Fractions containing vitronectin-binding activity, assayed on microtiter plates with immobilised human vitronectin, were collected and SDS-PAGE analysis showed the content to be a single protein band at the 60 kDa position. In Western blot experiments the protein transblotted onto nitrocellulose membranes could bind soluble vitronectin. Its amino-terminal amino acid sequences showed a striking similarity with those of a 60 kDa heparan sulfate-binding protein from the same staphylococcal strain (Liang, O.D. et al. (1992) Infect. Immun. 60, 899-906), suggesting that they are identical molecules. This was supported by ligand blotting experiments where both vitronectin and heparan sulfate were shown to bind to the same protein band in parallel strips.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7612648     DOI: 10.1016/0167-4838(95)00076-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epithelium.

Authors:  Donavon J Hess; Michelle J Henry-Stanley; Stanley L Erlandsen; Carol L Wells
Journal:  Med Microbiol Immunol       Date:  2005-12-24       Impact factor: 3.402

2.  Transcription of Staphylococcus aureus fibronectin binding protein genes is negatively regulated by agr and an agr-independent mechanism.

Authors:  P Saravia-Otten; H P Müller; S Arvidson
Journal:  J Bacteriol       Date:  1997-09       Impact factor: 3.490

3.  Clusterin, a putative complement regulator, binds to the cell surface of Staphylococcus aureus clinical isolates.

Authors:  S R Partridge; M S Baker; M J Walker; M R Wilson
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

4.  Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins.

Authors:  M Hussain; K Becker; C von Eiff; J Schrenzel; G Peters; M Herrmann
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

5.  A lithium chloride-extracted, broad-spectrum-adhesive 42-kilodalton protein of Staphylococcus epidermidis is ornithine carbamoyltransferase.

Authors:  M Hussain; G Peters; G S Chhatwal; M Herrmann
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  SdrI, a serine-aspartate repeat protein identified in Staphylococcus saprophyticus strain 7108, is a collagen-binding protein.

Authors:  Türkan Sakinc; Britta Kleine; Sören G Gatermann
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

7.  Neisseria meningitidis Opc invasin binds to the sulphated tyrosines of activated vitronectin to attach to and invade human brain endothelial cells.

Authors:  Claudia Sa E Cunha; Natalie J Griffiths; Mumtaz Virji
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

8.  Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions.

Authors:  Alex J McCarthy; Jodi A Lindsay
Journal:  BMC Microbiol       Date:  2010-06-15       Impact factor: 3.605

9.  Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack.

Authors:  Teresia Hallström; Melanie Uhde; Birendra Singh; Christine Skerka; Kristian Riesbeck; Peter F Zipfel
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

10.  Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif.

Authors:  Teresia Hallström; Birendra Singh; Peter Kraiczy; Sven Hammerschmidt; Christine Skerka; Peter F Zipfel; Kristian Riesbeck
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.